Good Lifestyle

The content of your pharmacy cabinet can go from daily vitamins useful to essential prescriptions and all between . Whether it is taking care of the muscles, tackling the flu suddenly or to face a chronic illness, many people count on these items to help them stay abreast of their health and to improve their quality of life. But before you reach your next dose, you may want to take a moment to check what you have on hand. Indeed, more than 80 prescription and over -the -counter medications (OTC) had just recalled due to security problems. Read the rest for more information and to determine if you are in danger.

Read this then: 800,000 bottles of fabric softener recalled due to carcinogenic chemicals .

On April 26, the Food & Drug Administration (FDA) announced that the Illinois Akorn Operation Company LLC had published a voluntary reminder for a wide range of its range of drugs, including over -the -counter medications, prescription drugs and pets for pets. The company claims that the items have been distributed nationally to wholesalers, retailers, manufacturers, medical facilities and online reconditioners to consumers.

In total, 75 elements intended for human use are affected, including all elements such as artificial tears, lidocaine ointment, the oral solution of Lorazepam and injection bottles, vitamin D drops, the Spray Nasal Olopatadine and the eye drops of sodium chloride, among others. The complete list of articles is published on a Seven pages document in the opinion of the agency.

The recall also affects nine products of animal origin, in particular artificial tears, an injection solution for ketamine, an ointment with a neopoly-bac eye, etc. The complete list of pets for pets is published on a separate document .

According to the opinion of the agency, Akorn filed a bankruptcy file in chapter 7 on February 23. He has since closed all operations and has ended all of his employees in his national American production sites. The company claims that it draws articles from the market, because without its internal quality insurance program in place, it will no longer be able to support or guarantee that the items will meet specifications thanks to the rest of their shelf life.

"The cessation of the quality program would lead to the incapacity of the company to ensure that the products respond to the characteristics of identity, strength, quality and purity that they are presumed or represented to own who Make the products falsified, "wrote the company in its recall notice. "Although specific risks of patients to use these falsified products cannot always be identified or evaluated, it is not possible either to exclude the risks of patients resulting from the use of these products."

In relation: For more information, register for our daily newsletter .

The company says that it is currently alerting all distributors to recall via direct mail. Until now, no adverse events linked to the affected elements has been reported.

However, the company requests the destruction of any product recalled on the market. All patients who have affected items must throw them immediately and contact their doctor or health care provider.

Those who have questions about the recall can reach Akorn by calling a hotline listed in the published opinion. Anyone who has experienced health problems - including animals in care - after taking products must immediately contact his health care provider or veterinarian.

This is not the only recent example of a company firing over -the -counter medicines, prescription drugs or healthy shelves. On March 22, the FDA announced that LLC Laboratories Ascend had voluntarily recalled his dabigatran capsules, etc. AE0FCC31AE342FD3A1346EBB1F342FCB

The company said they made its decision after discovering that the drug contained a Nitrosamine impurity - In particular the N -Nitrosodimethylamine - in quantity higher than the levels of the acceptable daily contribution of the FDA (ADI). While people are regularly exposed to nitrosamines in daily life through water and food, including dairy products, grilled meats and certain vegetables, prolonged exposure to high quantities can increase the risk of cancer.

Food supplements have also been assigned. On April 22, Food & Drug Administration (FDA) announced that Europharma, Inc. had published a voluntary reminder for its naturally bioactive terry products of vitamin B and Euromedica Active B Complex 60. The company declared that it has drawn the vitamins from the market after discovering that it contained an ingredient with an undeclared milk allergen. This created a serious health risk for anyone who suffers from an allergy or a milk sensitivity.